Related Experiment Video
Updated: Jul 12, 2026

An In Vivo Estrogen Deficiency Mouse Model for Screening Exogenous Estrogen Treatments of Cardiovascular Dysfunction After Menopause
Published on: August 13, 2019
Preventing cardiovascular disease in women: an update
1Emory University School of Medicine, Grady Memorial Hospital, Emory Heart & Vascular Center, Atlanta, Georgia, USA. mwenger@emory.edu
Insights
Coronary heart disease (CHD) remains a leading cause of death for US women. Guidelines recommend lifestyle changes and medications, yet women are often underdiagnosed and undertreated for cardiovascular risk factors.
Area of Science:
- Cardiology
- Women's Health
- Preventive Medicine
Background:
- Coronary heart disease (CHD) is the primary cause of mortality for women in the United States.
- American Heart Association (AHA) guidelines provide evidence-based recommendations for CHD prevention in women.
- Key risk factors include smoking, inactivity, poor diet, dyslipidemia, hypertension, diabetes, and metabolic syndrome.
Purpose of the Study:
- To summarize current recommendations for CHD prevention in women.
- To highlight the role of lifestyle interventions and pharmacotherapy.
- To address the underrecognition and undertreatment of cardiovascular risk in women.
Main Methods:
- Review of American Heart Association (AHA) guidelines.
- Analysis of risk factors contributing to CHD in women.
- Discussion of lifestyle and pharmacologic interventions.
- Consideration of new clinical trial findings relevant to women.
Main Results:
- Lifestyle interventions significantly reduce CHD risk.
- Many women require pharmacotherapy for hypertension, dyslipidemia, and diabetes.
- High coronary risk in women is often underrecognized.
- Women are frequently undertreated with statins and other therapies.
Conclusions:
- Adherence to guidelines and timely intervention are crucial for reducing CHD mortality in women.
- Addressing underdiagnosis and undertreatment is essential for improving cardiovascular outcomes.
- Further research and clinical trial data specific to women may refine risk prediction and treatment strategies.
Abstract:
Coronary heart disease (CHD) continues to be the leading cause of death among women in the United States. Evidence-based guidelines of the American Heart Association (AHA) offer clinicians recommendations for preventing CHD in women delineating particular lifestyle, risk factor, and pharmacologic interventions. Cigarette smoking, physical inactivity, inappropriate diet, dyslipidemia, hypertension, diabetes mellitus, and metabolic syndrome contribute to the risk of CHD in women, as in men. Lifestyle interventions substantially reduce that risk. Many women, however, require pharmacotherapy to control hypertension, dyslipidemia, and diabetes to levels required for decreasing risk. New findings from clinical trials featuring women may enhance their CHD risk prediction and treatment. However, high coronary risk in many women continues to be underrecognized, and women remain undertreated with statins and other therapeutic agents.
Related Concept Videos
Coronary Artery Disease IV: Preventive Measures
Atherosclerosis III: Management
Coronary Artery Disease I: Introduction
Ischemic Heart Disease: Overview
Atherosclerosis, the primary malefactor, orchestrates this dangerous condition. It manifests as the accumulation of fatty deposits, akin to insidious plaques, within arterial walls. As time elapses, these plaques metamorphose, hardening and narrowing...
Assessment of the Cardiovascular System I: Subjective Data
Initial Enquiry
Ask the patient about their primary concern and thoroughly explore all reported symptoms.
Medical History
Investigate past illnesses affecting the cardiovascular system, such as angina, anemia, rheumatic fever, congenital heart disease, stroke, thrombophlebitis, dysrhythmias, varicosities
Inquire about symptoms...
Coronary Artery Disease V: Interprofessional Care
